Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Back to Catecholaminergic Polymorphic Ventricular Tachycardia

Catecholaminergic Polymorphic Ventricular Tachycardia — NIH Grants & Funding

Active and recent NIH-funded research on Catecholaminergic Polymorphic Ventricular Tachycardia. Data from NIH RePORTER, last 36 months.

MONDO:0017990

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Catecholaminergic Polymorphic Ventricular Tachycardia has active NIH research funding with 12 funded grants totaling $10.1M.

12funded grants from NIH

Portfolio: $4.1MCumulative: $10.1M5 active7 completed14 PIs10 institutions

By Research Theme

Basic Science

Translational

Clinical

Gene/Cell Therapy

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$2.6M

FY22

$2.8M

FY23

$2.9M

FY24

$1.6M

FY25

$148K

FY26

By Funding Mechanism

R01

F30

F31

F32

K08

R16

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Catecholaminergic Polymorphic Ventricular Tachycardia. Strongest funded area: Basic Science. Largest gap: Basic Science.

Basic ScienceFunded, Few Publications

7 funded grants in Basic Science but only 0 related publications found for catecholaminergic polymorphic ventricular tachycardia. This may indicate early-stage research that hasn't yet produced published results.

Translational / Drug DevelopmentFunded, Few Publications

3 funded grants in Translational / Drug Development but only 0 related publications found for catecholaminergic polymorphic ventricular tachycardia. This may indicate early-stage research that hasn't yet produced published results.

Adjacent Research(4 grants)

These grants mention Catecholaminergic Polymorphic Ventricular Tachycardia as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(4)

OtherR01Active

Development of Mirror-Image Natural Products as Antiarrhythmic Therapeutics

Johnston, Jeffrey·VANDERBILT UNIVERSITY·Nashville, TN

$744,145 (FY2025)

NIH RePORTER

OtherR01Active

Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias

Alvarado, Francisco et al.·UNIVERSITY OF WISCONSIN-MADISON·MADISON, WI

$604,478 (FY2026)

NIH RePORTER

OtherR01Completed

Regulation of gene transcription and alternative splicing by a long non-coding RNA

Song, Kunhua et al.·UNIVERSITY OF SOUTH FLORIDA·TAMPA, FL

$505,728 (FY2025)

NIH RePORTER

OtherR35Completed

Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia

Knollmann, Bjorn·VANDERBILT UNIVERSITY MEDICAL CENTER·NASHVILLE, TN

$1,020,000 (FY2025)

NIH RePORTER

NIH Grants & Funding for Catecholaminergic Polymorphic Ventricular Tachycardia | Kisho | Kisho

Kisho

Catecholaminergic Polymorphic Ventricular Tachycardia — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(4 grants)

Other(4)

Development of Mirror-Image Natural Products as Antiarrhythmic Therapeutics

Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias

Regulation of gene transcription and alternative splicing by a long non-coding RNA

Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia

Top Funded Institutions

Top Principal Investigators